{{Rsnum
|rsid=17780102
|Chromosome=12
|position=3599443
|Orientation=plus
|GMAF=0.3779
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 45.1 | 39.8
| HCB | 27.2 | 46.3 | 26.5
| JPT | 31.0 | 48.7 | 20.4
| YRI | 4.1 | 33.3 | 62.6
| ASW | 3.5 | 36.8 | 59.6
| CHB | 27.2 | 46.3 | 26.5
| CHD | 23.1 | 54.6 | 22.2
| GIH | 9.9 | 45.5 | 44.6
| LWK | 5.5 | 33.6 | 60.9
| MEX | 19.0 | 46.6 | 34.5
| MKK | 7.1 | 32.1 | 60.9
| TSI | 8.8 | 42.2 | 49.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22688887
|Title=Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}